MPZL2 Lysate (NBL1-13215)
MPZL2 Lysate
|
This product is fully covered under the Novus guarantee+ Policy.
Click
here for details.
|
|
Distributor Data...
|
|
EVA, EVA1 |
|
|
MPZL2 Lysate Summary: | | | Specificity: | Homo sapiens myelin protein zero-like 2 (MPZL2), transcript variant 2, mRNA. |
|---|
| |
| | Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur. |
View Additional MPZL2 Products MPZL2 Lysate Details: | Immunogen: | The lysate was created in HEK293T cells, using plasmid ID RC223753 and based on accession number NM_144765. The protein contains a C-terminal DDK tag. |
|---|
Lysate Details: | Type: | Overexpression | Life Stage: | Adult | | Protein State: | Native | Tissue Condition: | Normal | | Sub-cellular Fraction: | Whole |
| Uses: | This product is intended for use as a positive control in Western Blot. You will receive the lysate (100ug), and an empty vector negative control (100 ug). |
|---|
| Dilutions: | Western Blot |
|---|
| TMW: | 21.7 kDa |
|---|
| Unit Size: | 0.1 mg |
|---|
| Concentration: | 1.0 mg/ml |
|---|
|
Notes: This product is manufactured by and sold under license from OriGene Technologies and its use is limited solely for research purposes. Please note that “1 mg/ml” refers to the total protein concentration and that the specific protein concentration is not determined at this time. Packaging: | Storage: | Store at -80 °C. Avoid freeze-thaw cycles. |
|---|
| Buffer: | RIPA buffer |
|---|
| Limitations: | This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months. |
|---|
Background: Thymus development depends on a complex series of interactions between thymocytes and the stromal component of the organ. Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous to the myelin protein zero and, in thymus-derived epithelial cell lines, is poorly soluble in nonionic detergents, strongly suggesting an association to the cytoskeleton. Its capacity to mediate cell adhesion through a homophilic interaction and its selective regulation by T cell maturation might imply the participation of EVA in the earliest phases of thymus organogenesis. The protein bears a characteristic V-type domain and two potential N-glycosylation sites in the extracellular domain; a putative serine phosphorylation site for casein kinase 2 is also present in the cytoplasmic tail. Two transcript variants encoding the same protein have been found for this gene. Transcript Variant: This variant (2) differs in the 3' UTR compared to variant 1 and is the shorter transcript.
|
Images (1) Reviews (0) Related Products (10)
|
Jump to: Images, Ask a Question
|
Working with MPZL2
MPZL2 Lysate Images (1) Western Blot: MPZL2 Lysate [NBL1-13215] - Western Blot experiments.
Left-Control; Right -Over-expression Lysate for MPZL2 |
|
|
|
|
|
|
|
Ask a Scientist
Can't find an answer to your question about MPZL2? Ask us by using live
chat or by submitting your questions below:
|
|